Modulation of the hypoxic response following partial bladder outlet obstruction

Journal of Urology

Volumn 188, Issue 4 SUPPL., 2012, Pages 1549-1554

  Drzewiecki, Beth A ^a   Anumanthan, Govindaraj ^a   Penn, Heidi A ^a   Tanaka, Stacy T ^a   Thomas, John C ^a   Adams, Mark C ^a   Brock III, John W ^a   Pope IV, John C ^a   Matusik, Robert J ^a   Hayward, Simon ^a   Clayton, Douglass B ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

2 methoxyestradiol; hypoxia inducible factor 1, alpha subunit; urinary bladder neck obstruction

Indexed keywords

2 METHOXYESTRADIOL; CHOLESTEROL; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PIMONIDAZOLE; PLACEBO; PROTEIN LYSINE 6 OXIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER NECK STENOSIS; CONTROLLED STUDY; ENZYME INDUCTION; FEMALE; HYPOXEMIA; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84866085566     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.02.037     Document Type: Article

References (27)

1. M.A. Ghafar, A. Shabsigh, P. Chichester Effects of chronic partial outlet obstruction on blood flow and oxygenation of the rat bladder J Urol 167 2002 1508
2. P.J. Hoskin, A. Sibtain, F.M. Daley GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON Br J Cancer 89 2003 1290
3. D.F. Higgins, K. Kimura, W.M. Bernhardt Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition J Clin Invest 117 2007 3810
4. C.J. Schofield, P.J. Ratcliffe Oxygen sensing by HIF hydroxylases Nat Rev Mol Cell Biol 5 2004 343
5. V.H. Haase Pathophysiological consequences of HIF activation: HIF as a modulator of fibrosis Ann N Y Acad Sci 1177 2009 57
6. J.E. Greenland, A.F. Brading The effect of bladder outflow obstruction on detrusor blood flow changes during the voiding cycle in conscious pigs J Urol 165 2001 245
7. D.F. Higgins, M.P. Biju, Y. Akai Hypoxic induction of CTGF is directly mediated by HIF-1 Am J Physiol Renal Physiol 287 2004 F1223
8. G.L. Semenza Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics Oncogene 29 2010 625
9. S.L. Mooberry Mechanism of action of 2-methoxyestradiol: new developments Drug Resist Updat 6 2003 355
10. C.M. Becker, N. Rohwer, T. Funakoshi 2-methoxyestradiol inhibits hypoxia-inducible factor-1{alpha} and suppresses growth of lesions in a mouse model of endometriosis Am J Pathol 172 2008 534
11. Y.S. Chua, Y.L. Chua, T. Hagen Structure activity analysis of 2-methoxyestradiol analogues reveals targeting of microtubules as the major mechanism of antiproliferative and proapoptotic activity Mol Cancer Ther 9 2010 224
12. L.L. Woo, S.T. Tanaka, G. Anumanthan Mesenchymal stem cell recruitment and improved bladder function after bladder outlet obstruction: preliminary data J Urol 185 2011 1132
13. M. Martinez-Ferrer, J.M. Iturregui, C. Uwamariya Role of nicotinic and estrogen signaling during experimental acute and chronic bladder inflammation Am J Pathol 172 2008 59
14. H.D. Love, S.E. Booton, B.E. Boone Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer PLoS One 4 2009 e8384
15. G. Zhou, L.A. Dada, M. Wu Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1 Am J Physiol Lung Cell Mol Physiol 297 2009 L1120
16. C. Corpechot, V. Barbu, D. Wendum Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis Hepatology 35 2002 1010
17. R.M. Levin, L.J. O'Connor, R.E. Leggett Focal hypoxia of the obstructed rabbit bladder wall correlates with intermediate decompensation Neurourol Urodyn 22 2003 156
18. K.J. Aitken, C. Tolg, T. Panchal Mammalian target of rapamycin (mTOR) induces proliferation and de-differentiation responses to three coordinate pathophysiologic stimuli (mechanical strain, hypoxia, and extracellular matrix remodeling) in rat bladder smooth muscle Am J Pathol 176 2010 304
19. W.L. Dahut, N.J. Lakhani, J.L. Gulley Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors Cancer Biol Ther 5 2006 22
20. D. Matei, J. Schilder, G. Sutton Activity of 2 methoxyestradiol (Panzem NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: a Hoosier Oncology Group trial Gynecol Oncol 115 2009 90
21. D. Zhou, G.A. Matchett, V. Jadhav The effect of 2-methoxyestradiol, a HIF-1 alpha inhibitor, in global cerebral ischemia in rats Neurol Res 30 2008 268
22. N.J. Mabjeesh, D. Escuin, T.M. LaVallee 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF Cancer Cell 3 2003 363
23. K.J. Aitken, D.J. Bagli The bladder extracellular matrix Part I: architecture, development and disease Nat Rev Urol 6 2009 596
24. D.F. Higgins, K. Kimura, M. Iwano Hypoxia-inducible factor signaling in the development of tissue fibrosis Cell Cycle 7 2008 1128
25. T.G. Voloshenyuk, E.S. Landesman, E. Khoutorova Induction of cardiac fibroblast lysyl oxidase by TGF-β1 requires PI3K/Akt, Smad3, and MAPK signaling Cytokine 55 2011 90
26. A.R. Sharif-Afshar, J.M. Donohoe, J.C. Pope 4th Stromal hyperplasia in male bladders upon loss of transforming growth factor-beta signaling in fibroblasts J Urol 174 2005 1704
27. A. Weidemann, R.S. Johnson Biology of HIF-1alpha Cell Death Differ 15 2008 621